OneSource Specialty Pharma Limited Financials: Revenue, Profit, Balance Sheet & Cash Flow

OneSource Specialty Pharma Limited Score & Ratio Trend

Date	Score	P/E	P/B	D/E	Price
Oct 2026	19,550	-359.7	3.01	0.26	1,528.60
Oct 2026	19,256	-343.8	2.87	0.26	1,461.30

Line Item	Jun 2026	Mar 2026	Dec 2025	Sep 2025
Revenue	4,490,230,000.0	4,282,170,000.0	2,903,400,000.0	3,757,630,000.0
Net Profit	249,970,000.0	45,970,000.0	-886,990,000.0	104,850,000.0
EPS	2.2	0.4	-7.7	0.9

Line Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	14,215,900,000.0	14,448,530,000.0	1,719,190,000.0	387,140,000.0
Net Profit	-738,030,000.0	-179,710,000.0	-3,911,650,000.0	-7,998,300,000.0
EPS	-6.4	-1.6	-34.2	-69.9

Line Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Total Assets	82,100,140,000.0	75,502,420,000.0	13,086,110,000.0	20,088,080,000.0
Total Liabilities	23,787,250,000.0	16,696,630,000.0	9,128,980,000.0	12,233,550,000.0
Total Equity	58,312,890,000.0	58,805,790,000.0	3,957,130,000.0	7,854,530,000.0

OneSource Specialty Pharma Limited owed ₹0.29 for every ₹1 it owned in Mar 2026, down from ₹0.61 in Mar 2023.

Period	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Owes vs Owns	0.29×	0.22×	0.70×	0.61×

Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.

What it owns — Mar 2026

Cash & short-term investments 0.6%Receivables 8.4%Inventory 5.3%Fixed assets (tangible) 17.7%Intangible assets 64.6%Other assets 3.2%

How it's funded — Mar 2026

Short-term debt 8.7%Long-term debt 6.9%Payables 4.6%Other liabilities 8.9%Shareholders' equity 71.0%

Line Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Assets
Cash & short-term investments	47.5	210.5	22.3	9.5
Receivables	690.2	416.6	55.2	3.8
Inventory	439.0	158.1	11.2	133.2
Fixed assets (tangible)	1,449.6	1,004.4	743.5	1,369.4
Intangible assets	5,306.9	5,378.2	325.4	337.7
Long-term investments	10.2	6.9	3.8	0.0
Other assets	266.5	375.5	147.1	155.3
Liabilities & equity
Short-term debt	712.6	552.3	290.6	501.8
Long-term debt	563.7	219.3	271.6	334.9
Payables	374.6	175.5	81.0	94.8
Other liabilities	727.9	722.6	269.7	291.8
Shareholders' equity	5,831.3	5,880.6	395.7	785.5
Net tangible assets	524.3	502.4	70.3	447.7

Line Item	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Operating Activities	85,230,000.0	-678,540,000.0	-1,072,110,000.0	-1,627,650,000.0
Investing Activities	-4,949,840,000.0	-2,010,810,000.0	5,105,450,000.0	-678,340,000.0
Financing Activities	3,594,390,000.0	4,120,080,000.0	-3,905,440,000.0	1,183,180,000.0